Skip to content

A Questionnaire for Endoscopic Prediction Improvement of Gastrointestinal Cancer

A Self-rating Risk Factor Questionnaire for the Improvement of Endoscopic Prediction of Gastrointestinal Cancer: a Big-data-based Diagnostic Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04071431
Enrollment
34906
Registered
2019-08-28
Start date
2019-05-29
Completion date
2021-04-30
Last updated
2019-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Detection of Cancer

Keywords

Early Detection of cancer, Gastrointestinal Neoplasms, Endoscopy, Gastrointestinal

Brief summary

Despite improvements in a range of chemo, radio and surgical therapies, the overall survival at 5 years from gastrointestinal cancer remains poor. Endoscopic early diagnosis is a key strategy to improve survival but the detection rate of early cancer varies among different countries. Risk factor questionnaire result is easy to be obtained and may be of great help for improving the detection rate. The aim of this research is to validate a risk factor questionnaire to help predict gastrointestinal cancer therefore allowing earlier diagnosis and higher detection rate.

Interventions

OTHERResult masking

The quality control system randomly shows the RFQ result to the endoscopists and keep 50% of the RFQ results are not known (deliberately showing N/A) by the endoscopists before and during the endoscopy.

Sponsors

Yanqing Li
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients aged more than 18 years with or without GI symptoms attending for endoscopy.

Exclusion criteria

* Patients unable to cooperated the endoscopy or unable to complete it. People with endoscopy contraindications are naturally excluded.

Design outcomes

Primary

MeasureTime frameDescription
Rate changeup to 24 monthsThe endoscopic detection rate change of precancerous lesions and early GI cancer with the help of self-rating RFQ for the prediction of GI cancer.

Countries

China

Contacts

Primary ContactYanqing LI, Doctor
liyanqing@sdu.edu.cn13573106261
Backup ContactZhen Li, Doctor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026